These resources are available to offer greater detail on the benefits of RELiZORB, and how it mimics pancreatic lipase function to deliver absorbable fats to enterally fed patients.
In these videos, a team of clinical experts explore issues associated with fat malabsorption and how RELiZORB may help address these challenges in patients who require enteral feeding.
Challenging Cases in Enterally Fed Patients: Post Surgery, Oncology, and other EPI Conditions
Presented by Jaclyn Moore, MS - Dietetics
Challenges of Fat Malabsorption in Enterally Fed ICU Patients
Presented by David Clay Evans, MD, FACS
RELiZORB: Hydrolyze Fats, Normalize Absorption of Fatty Acids
Presented by Jeanette Hasse, PhD, RD, LD, FADA, CNSC
Fat Malabsorption in Enterally Fed Patients: Challenging Cases in Pediatric Gastroenterology
Presented by Beth Lyman, MSN, RN, FASPEN
Fat Malabsorption in Enterally Fed Patients: Challenging Cases in Patients with End Stage Lung Disease
Bekah Sommer, RD, CD
In-Service for Inpatient RELiZORB Use
Presented by Molly Bigford, RD
Learn more about RELiZORB and how it may help patients with specific clinical conditions associated with fat malabsorption.
For more information on how to order RELiZORB, contact RELiZORB Support Services at 1-844-632-9271.